These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35444012)

  • 1. Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer.
    Kajimoto Y; Shibutani T; Nagao S; Yamaguchi S; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Honda K; Igarashi A
    Int J Gynecol Cancer; 2022 Apr; ():. PubMed ID: 35444012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients.
    Durber K; Halkett GK; McMullen M; Nowak AK
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):377-387. PubMed ID: 33567158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation and validation of the Traditional Chinese version of the COmprehensive Score for financial Toxicity-Functional Assessment of Chronic Illness Therapy (Version 2).
    Chan DNS; Choi KC; Ng MSN; Xing W; Law BMH; Ho PS; Au C; Chan M; Tong M; Ling WM; Chan M; Mak SSS; Chan RJ; So WKW
    Health Qual Life Outcomes; 2021 Jan; 19(1):17. PubMed ID: 33419447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.
    Shim S; Kang D; Kim N; Han G; Lim J; Kim H; Park J; Lee M; Lee JE; Kim SW; Yu J; Chae BJ; Ryu JM; Nam SJ; Lee SK; Cho J
    Cancer Res Treat; 2022 Jul; 54(3):834-841. PubMed ID: 34645130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
    Kajimoto Y; Honda K; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Shibutani T; Nagao S; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Fujiwara K; Igarashi A
    Int J Clin Oncol; 2023 Mar; 28(3):454-467. PubMed ID: 36648710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of FinTox: A new screening tool to assess cancer-related financial toxicity.
    Badr H; Han J; Mims M
    Cancer Med; 2024 Aug; 13(15):e7306. PubMed ID: 39113222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial toxicity in gynecologic oncology: a multi-practice survey.
    Smith AJ; Sharma MH; Powell K; Doherty M; Hinkle SN; Ko EM
    Int J Gynecol Cancer; 2024 Jun; 34(6):919-925. PubMed ID: 38346844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
    de Souza JA; Yap BJ; Wroblewski K; Blinder V; Araújo FS; Hlubocky FJ; Nicholas LH; O'Connor JM; Brockstein B; Ratain MJ; Daugherty CK; Cella D
    Cancer; 2017 Feb; 123(3):476-484. PubMed ID: 27716900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crowdsourcing to measure financial toxicity in gynecologic oncology.
    Esselen KM; Stack-Dunnbier H; Gompers A; Hacker MR
    Gynecol Oncol; 2021 May; 161(2):595-600. PubMed ID: 33551197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial validation of the Yin-Yang Assessment Questionnaire for persons with diabetes mellitus.
    Wong YC; Pang MC
    World J Diabetes; 2015 Sep; 6(11):1198-206. PubMed ID: 26380063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial toxicity in patients with gynecologic malignancies: a cross sectional study.
    Zeybek B; Webster E; Pogosian N; Tymon-Rosario J; Balch A; Altwerger G; Clark M; Menderes G; Huang G; Azodi M; Ratner ES; Schwartz PE; Santin AD; Andikyan V
    J Gynecol Oncol; 2021 Nov; 32(6):e87. PubMed ID: 34431257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the reliability and validity of comprehensive score for financial toxicity (COST) among radiation oncology patients in India: a cross-sectional pilot study.
    Dar MA; Chauhan R; Sharma KK; Trivedi V; Dhingra S; Murti K
    Ecancermedicalscience; 2021; 15():1219. PubMed ID: 34158823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of self-reported financial toxicity measures in cancer survivors: a systematic review.
    Zhu Z; Xing W; Wen H; Sun Y; So WKW; Lizarondo L; Peng J; Hu Y
    BMJ Open; 2022 Jun; 12(6):e057215. PubMed ID: 35750459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COmprehensive Score for financial Toxicity in China: Validation and Responsiveness.
    Yu HH; Yu ZF; Li H; Zhao H; Sun JM; Liu YY
    J Pain Symptom Manage; 2021 Jun; 61(6):1297-1304.e1. PubMed ID: 33412268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system.
    Riva S; Arenare L; Di Maio M; Efficace F; Montesarchio V; Frontini L; Giannarelli D; Bryce J; Del Campo L; De Lorenzo F; Iannelli E; Traclò F; Gitto L; Jommi C; Vaccaro CM; Barberio D; Cinieri S; Porta C; Del Mastro L; Zagonel V; Cogoni AA; Bordonaro R; Gimigliano A; Piccirillo MC; Guizzaro L; Gallo C; Perrone F
    BMJ Open; 2021 Oct; 11(10):e049128. PubMed ID: 34670762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation and Validation of the Comprehensive Score of Financial Toxicity for Cancer Patients Into Arabic.
    Mejri N; Rachdi H; Mnif A; Berrazega Y; Benna HE; Labidi S; Boussen H
    J Nurs Meas; 2022 Dec; 30(4):673-682. PubMed ID: 34518422
    [No Abstract]   [Full Text] [Related]  

  • 18. Re-Validation of the COmprehensive Score for Financial Toxicity (COST): Assessing the Scale's Utility in Chronic Disease Populations.
    Pavela G; Fifolt M; Tison SE; Allison M; Burton BS; Ford EW
    Health Serv Insights; 2021; 14():11786329211057352. PubMed ID: 34916802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Psychometric Validity of the Epistaxis Severity Score: Internal Consistency and Test-Retest Reliability.
    Gong AJ; Bolsegui ML; Lee EE; Mathai SC; Weiss CR
    Am J Rhinol Allergy; 2024 Jan; 38(1):38-46. PubMed ID: 37822162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified Chinese version of the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire: cross-cultural adaptation, reliability, and validity for patients with cervical spondylotic myelopathy.
    Yao M; Li ZJ; Zhu B; Xu BP; Zhu S; Pan YF; Wang XT; Tian ZR; Deng Z; Ye J; Wang YJ; Cui XJ
    Disabil Rehabil; 2022 Apr; 44(8):1516-1523. PubMed ID: 33016146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.